Cargando…
Preliminary study on the efficacy of xerostomia treatment with sialocentesis targeting thyroid disease patients given radioiodine therapy
BACKGROUND: Radioiodine therapy has been widely used for thyroid disease patients, but hyposalivation and xerostomia may occur in 10~30% of patients. Sialocentesis is a procedure that removes inflammatory substances in the salivary duct and expands the duct for the secretion and delivery of saliva....
Autores principales: | Kim, Euy-Hyun, Lee, Dong-Keon, Kim, Chang-Woo, Song, In-Seok, Jun, Sang-Ho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6728110/ https://www.ncbi.nlm.nih.gov/pubmed/31544098 http://dx.doi.org/10.1186/s40902-019-0223-3 |
Ejemplares similares
-
Alterations in Oral Microbiota of Differentiated Thyroid Carcinoma Patients With Xerostomia After Radioiodine Therapy
por: Lin, Baiqiang, et al.
Publicado: (2022) -
Xerostomia and Its Cellular Targets
por: Kim, Yoon-Jung
Publicado: (2023) -
Defining Radioiodine-Refractory Differentiated Thyroid Cancer: Efficacy and Safety of Lenvatinib by Radioiodine-Refractory Criteria in the SELECT Trial
por: Kiyota, Naomi, et al.
Publicado: (2017) -
Tunicamycin as a Novel Redifferentiation Agent in Radioiodine Therapy for Anaplastic Thyroid Cancer
por: Choi, Yoon Ju, et al.
Publicado: (2021) -
Oral microbiota in xerostomia patients - A preliminary study
por: Weng, Chen-Tsung, et al.
Publicado: (2022)